Decriz (eplerenone) coated tablets 25 mg. №30

$37.50

Manufacturer: Poland

Purpose: Blocks aldosterone receptors, treats heart failure and hypertension.

SKU: MED57619 Category:

Description

Decriz (eplerenone) Coated Tablets 25 mg. №30

Ingredients

Active ingredient: Eplerenone 25 mg.
Other ingredients: lactose monohydrate, corn starch, hypromellose, magnesium stearate, titanium dioxide, polyethylene glycol.

Dosage

Recommended dosage: The usual starting dose is 25 mg once daily. Dosage may be increased to a maximum of 50 mg once daily based on blood pressure response.

Indications

Decriz (eplerenone) tablets are indicated for the treatment of hypertension to lower blood pressure.

Contraindications

Do not use Decriz tablets if you:

  • Are allergic to eplerenone or any other ingredients in the product.
  • Have severe kidney problems.
  • Are pregnant or breastfeeding.

Directions

Take Decriz tablets exactly as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water. It can be taken with or without food.

Scientific Evidence

Studies have shown that eplerenone, the active ingredient in Decriz tablets, is effective in reducing blood pressure in patients with hypertension. Research published in the Journal of Clinical Hypertension demonstrated the efficacy of eplerenone in improving cardiovascular outcomes.

Additional Information

It is important to note that Decriz tablets may interact with other medications, so inform your doctor about all the drugs you are taking. Regular monitoring of potassium levels is recommended during treatment with eplerenone.

Pharmacological Effects: Eplerenone is a selective aldosterone blocker that works by blocking the effects of aldosterone, a hormone that can raise blood pressure. By blocking aldosterone, eplerenone helps to lower blood pressure and reduce the strain on the heart.

Clinical Trials: Clinical trials have shown that eplerenone is well-tolerated and effective in the treatment of hypertension. A study published in the American Journal of Hypertension found that eplerenone significantly reduced blood pressure compared to a placebo, with a good safety profile.